quinidine has been researched along with Dysarthria, Pseudobulbar in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, C; Formella, AE; Hammond, FM; Ledon, F; Sauve, W | 1 |
| Fralick, M; Kesselheim, AS; Sacks, CA | 1 |
| Casselman, J; Patatanian, E | 1 |
| Appel, SH; Formella, AE; Lomen-Hoerth, C; Pattee, GL; Pope, LE; Wymer, JP | 1 |
| Cutler, AJ; D'Amico, S; Davis, CS; Doody, RS; Ledon, F; Shin, P; Siffert, J; Yonan, C | 1 |
| Roman, MW | 1 |
| Alexander, DN; Cutler, AJ; D'Amico, S; Davis, CS; Doody, RS; Formella, AE; Hammond, FM; Ledon, F; Sauve, W; Shin, P; Siffert, J; Yonan, C; Zorowitz, RD | 1 |
| Stahl, SM | 1 |
| Reiman, AT; Schrader, JV; Wahler, RG | 1 |
| Sauvé, WM | 1 |
| Rosen, H | 1 |
| Haiman, G; Miller, A; Pratt, H | 1 |
| Miller, A; Pratt, H; Schiffer, RB | 1 |
| Appel, SH; Berg, JE; Bradley, WG; Brooks, BR; Olney, RK; Pope, LE; Smith, RA; Thisted, RA | 1 |
| Brooks, BR; Smith, RA | 1 |
| Hingorani, VN; Kittrelle, JP | 1 |
| Weintraub, D | 1 |
| Pope, LE; Schiffer, R | 1 |
| Miller, A; Panitch, H | 1 |
6 review(s) available for quinidine and Dysarthria, Pseudobulbar
| Article | Year |
|---|---|
Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
Topics: Clinical Trials as Topic; Crying; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Humans; Laughter; Pseudobulbar Palsy; Quinidine; Receptors, sigma; Sigma-1 Receptor; Treatment Outcome | 2014 |
Recognizing and treating pseudobulbar affect.
Topics: Dextromethorphan; Drug Combinations; Early Diagnosis; Excitatory Amino Acid Antagonists; Humans; Pseudobulbar Palsy; Quinidine | 2016 |
Dextromethorphan/quinidine sulfate for pseudobulbar affect.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Dextromethorphan; Drug Combinations; Humans; Pseudobulbar Palsy; Quinidine; Selective Serotonin Reuptake Inhibitors | 2008 |
Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.
Topics: Adrenergic alpha-Antagonists; Brain; Clinical Trials as Topic; Crying; Dextromethorphan; Excitatory Amino Acid Antagonists; Humans; Laughter; Pseudobulbar Palsy; Quinidine; Synaptic Transmission | 2011 |
Review of pseudobulbar affect including a novel and potential therapy.
Topics: Analgesics, Non-Narcotic; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Drug Therapy, Combination; Humans; Mood Disorders; Pseudobulbar Palsy; Quinidine | 2005 |
Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.
Topics: Animals; Brain; Dextromethorphan; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Multiple Sclerosis; Pseudobulbar Palsy; Quinidine | 2007 |
4 trial(s) available for quinidine and Dysarthria, Pseudobulbar
| Article | Year |
|---|---|
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study.
Topics: Adult; Brain Injuries, Traumatic; Dextromethorphan; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injury Severity Score; Male; Maximum Tolerated Dose; Middle Aged; Neuropsychological Tests; Patient Safety; Patient Selection; Prognosis; Prospective Studies; Pseudobulbar Palsy; Quinidine; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2018 |
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Aged, 80 and over; Cohort Studies; Crying; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Laughter; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Treatment Outcome; Young Adult | 2014 |
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Topics: Aged; Brain Injuries, Traumatic; Dementia; Dextromethorphan; Drug Administration Schedule; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Severity of Illness Index; Stroke; Treatment Outcome | 2016 |
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Double-Blind Method; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pseudobulbar Palsy; Quinidine; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2004 |
10 other study(ies) available for quinidine and Dysarthria, Pseudobulbar
| Article | Year |
|---|---|
Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.
Topics: Aged; Amyotrophic Lateral Sclerosis; Dementia; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Pseudobulbar Palsy; Quinidine; United States; United States Food and Drug Administration | 2019 |
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Dextromethorphan; Diarrhea; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Headache; Humans; Lewy Body Disease; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Urinary Tract Infections | 2016 |
NueDexta: A Treatment for Pseudobulbar Affect.
Topics: Affective Symptoms; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Humans; Pseudobulbar Palsy; Quinidine | 2015 |
Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression?
Topics: Dextromethorphan; Drug Combinations; Emotions; Excitatory Amino Acid Antagonists; Humans; Models, Theoretical; Pseudobulbar Palsy; Psychopharmacology; Quinidine; Receptors, Glutamate; Receptors, Serotonin; Receptors, sigma | 2016 |
Use of Compounded Dextromethorphan-Quinidine Suspension for Pseudobulbar Affect in Hospice Patients.
Topics: Aged, 80 and over; Crying; Dextromethorphan; Drug Combinations; Female; Hospice Care; Humans; Laughter; Male; Medical Audit; Pseudobulbar Palsy; Quinidine; Retrospective Studies; Treatment Outcome | 2017 |
Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect.
Topics: Acoustic Stimulation; Adult; Dextromethorphan; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pseudobulbar Palsy; Psychomotor Performance; Quinidine | 2009 |
Dextromethorphan/quinidine (Nuedexta) for pseudobulbar affect.
Topics: Dextromethorphan; Drug Combinations; Drug Interactions; Humans; Pseudobulbar Palsy; Quinidine | 2011 |
Treatment of pseudobulbar affect in ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain Chemistry; Dextromethorphan; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Pseudobulbar Palsy; Quinidine; Serotonin | 2005 |
Treatment of pseudobulbar affect in ALS: October 26 highlight and commentary.
Topics: Amyotrophic Lateral Sclerosis; Antitussive Agents; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Drug Combinations; Drug Resistance; Drug Synergism; Enzyme Inhibitors; Genetic Testing; Genotype; Humans; Pseudobulbar Palsy; Quinidine | 2005 |
Therapeutic options for emotional lability: current and emerging treatments.
Topics: Antidepressive Agents; Dextromethorphan; Drug Interactions; Humans; Mood Disorders; Pseudobulbar Palsy; Quinidine; Randomized Controlled Trials as Topic | 2005 |